Financhill
Back

Structure Therapeutics Vs. Texas Pacific Land Industry Stock Comparison

Sell
22

GPCR
Structure Therapeutics

Last Price:
33.72
Seasonality Move:
-20.36%
Buy
65

TPL
Texas Pacific Land

Last Price:
1,637.81
Seasonality Move:
6.3%
Sell
22
Structure Therapeutics (GPCR) is a Sell

Is Structure Therapeutics a Buy, Sell or Hold?

  • The current Structure Therapeutics [GPCR] share price is $33.75. The Score for GPCR is 22, which is 56% below its historic median score of 50, and infers higher risk than normal.
  • GPCR is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
65
Texas Pacific Land (TPL) is a Buy

Is Texas Pacific Land a Buy, Sell or Hold?

  • The current Texas Pacific Land [TPL] share price is $1,636.69. The Score for TPL is 65, which is 30% above its historic median score of 50, and infers lower risk than normal.
  • TPL is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.

GPCR Stock Price Chart

What is Structure Therapeutics's stock price today?

  • The Structure Therapeutics share price today is $33.75
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and GPCR is experiencing slight buying pressure.

TPL Stock Price Chart

What is Texas Pacific Land's stock price today?

  • The Texas Pacific Land share price today is $1,636.69
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and TPL is experiencing buying pressure, which is a positive indicator for future bullish movement.

GPCR Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -1.61 Sell
Relative Strength Index (14 RSI): 42.83 Sell
Chaikin Money Flow: 82910 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (33.52 - 39.4) Sell
Bollinger Bands (100): (35.33 - 41.31) Sell

TPL Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 134.69 Buy
Relative Strength Index (14 RSI): 73.01 Buy
Chaikin Money Flow: 291012 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (1166.38 - 1521.7) Buy
Bollinger Bands (100): (752.06 - 1225.16) Buy

GPCR Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 32.78 Buy
20-day SMA: 36.11 Sell
50-day SMA: 38.49 Sell
200-day SMA: 39.51 Sell
8-day EMA: 33.7 Buy
20-day EMA: 35.25 Sell
50-day EMA: 37.18 Sell
200-day EMA: 39.02 Sell

TPL Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 1542.2 Buy
20-day SMA: 1403.01 Buy
50-day SMA: 1161.08 Buy
200-day SMA: 795.53 Buy
8-day EMA: 1551.31 Buy
20-day EMA: 1419.73 Buy
50-day EMA: 1220.16 Buy
200-day EMA: 883.53 Buy

Structure Therapeutics Earnings Growth & GPCR Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.10 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.10 per share, and an increase next year of $0.15 per share.

Texas Pacific Land Earnings Growth & TPL Earnings Dates

  • Analysts estimate an earnings increase this quarter of $1.14 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.73 per share, and an increase next year of $2.99 per share.

Structure Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Texas Pacific Land Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):